Gastric Cancer Pharmaceutical and Healthcare Pipeline Review

Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and spread throughout the body. Gastric cancer is when such a condition occurs in the stomach and has the tendency to grow through the wall of the stomach to invade nearby organs including lymph nodes and lymph vessels. There are four types of cancers of the stomach namely, Adenocarcinoma, Lymphoma, Gastrointestinal stromal tumor (GIST), Carcinoid tumor and others such as squamous cell carcinoma, small cell carcinoma, and leiomyosarcomat that can start in the stomach, but are very rare.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1615782-global-gastric-cancer-market-report-2016-edition             

The causes of stomach cancer are rather unclear in medical study; however, there is a strong correlation between a diet high in smoked, salted and pickled foods, obesity and ageing. People with Helicobacter infections are also highly prone to gastric cancer. Symptoms of gastric cancer may include, fatigue, feeling bloated after eating, severe heartburn and indigestion, stomach pain, persistent and unexplained vomiting and nausea, unintentional weight loss, belching, anemia, and persistent ulcer. Its medical diagnosis techniques involve upper endoscopy, imaging tests and exploratory surgery. Treatment options include surgery, chemotherapy, radiotherapy and targeted therapy.

Global gastric cancer market is conspicuous by poor prognosis, because of the indolent nature of the disease. However, better diagnostic technology and shifting treatment market from chemotherapy to targeted therapies is expected to warrant positive growth in the years ahead. Rising oncology drug spending, ageing population, increasing obese population and rising global male population are expected to drive this growth. Certain trends in the global gastric cancer market include, a healthy pipeline of combinations targeted therapies, shifting focus towards molecular targeted therapies, and keen interest in eradication H. Pylori infection across the globe. The market is however, afflicted by certain challenges like low penetration of new targeted therapies and lack of reimbursement of cancer drugs.

The report provides an overview of the entire market through global and regional analysis. Prevalence and market value of gastric cancer across the globe and that of its various types and stages including advanced, her2 positive, stage III and metastatic gastric cancer have been analyzed.

Table of Content: Key Points

1. Market Overview

1.1 Introduction

1.2 Types

1.3 Stages

1.4 Causes & Prevention

1.5 Diagnosis

1.6 Treatment Options

2. Global Market

2.1 Global Gastric Cancer Market by Prevalence

2.2 Global Advanced Gastric Cancer Market by Value

3. Regional Markets

3.1. The U.S.

3.2 The European Union

3.3 The EU5

3.4 Japan

4. Market Dynamics

    4.1 Growth Drivers

4.1.1 Rising Spending on Targeted Cancer Therapies

4.1.2 Rising Oncology Drug Spending

4.1.3 Rising Ageing Population

4.1.4 Increasing Obese Population

4.1.5 Rising Global Male Population

4.1.6 Rising Cigarette Consumption

    4.2 Trends

4.2.1 Combinations Targeted Therapies under Development

4.2.2 Targeted Agents in Development by Pathways

4.2.3 Shifting Focus towards Molecular Targeted Therapies

4.2.4 H. Pylori Eradication

    4.3 Challenges

4.3.1 Low Penetration of New Targeted Therapies

4.3.2 Lack of Reimbursement of Cancer Drugs

5. Competitive Landscape

…Continued        

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1615782-global-gastric-cancer-market-report-2016-edition                

Contact Info:                                                         

NORAH TRENT                                                      

Partner Relations & Marketing Manager

[email protected]             

Ph: +1-646-845-9349 (US)                

Ph: +44 208 133 9349 (UK)                                                   

Get in touch:

LinkedIn: www.linkedin.com/company/4828928

Twitter: https://twitter.com/WiseGuyReports                                                                  

Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts   

Posted by Vivian Dsena on Thursday April 19 2018, 9:36 AM EDT. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0